Daily Papers

Large Vision Language Models (LVLMs) have achieved significant success across multi-modal tasks. However, the computational cost of processing long visual tokens can be prohibitively expensive on resource-limited devices. Previous methods have identified redundancy in visual tokens within the Large Language Model (LLM) decoder layers and have mitigated this by pruning tokens using a pre-defined or fixed ratio, thereby reducing computational overhead. Nonetheless, we observe that the impact of pruning ratio varies across different LLM layers and instances (image-prompt pairs). Therefore, it is essential to develop a layer-wise and instance-wise vision token pruning strategy to balance computational cost and model performance effectively. We propose ATP-LLaVA, a novel approach that adaptively determines instance-specific token pruning ratios for each LLM layer. Specifically, we introduce an Adaptive Token Pruning (ATP) module, which computes the importance score and pruning threshold based on input instance adaptively. The ATP module can be seamlessly integrated between any two LLM layers with negligible computational overhead. Additionally, we develop a Spatial Augmented Pruning (SAP) strategy that prunes visual tokens with both token redundancy and spatial modeling perspectives. Our approach reduces the average token count by 75% while maintaining performance, with only a minimal 1.9% degradation across seven widely used benchmarks. The project page can be accessed via https://yxxxb.github.io/ATP-LLaVA-page/.

Predicting ATP-Protein Binding sites in genes is of great significance in the field of Biology and Medicine. The majority of research in this field has been conducted through time- and resource-intensive 'wet experiments' in laboratories. Over the years, researchers have been investigating computational methods computational methods to accomplish the same goals, utilising the strength of advanced Deep Learning and NLP algorithms. In this paper, we propose to develop methods to classify ATP-Protein binding sites. We conducted various experiments mainly using PSSMs and several word embeddings as features. We used 2D CNNs and LightGBM classifiers as our chief Deep Learning Algorithms. The MP3Vec and BERT models have also been subjected to testing in our study. The outcomes of our experiments demonstrated improvement over the state-of-the-art benchmarks.

Understanding molecules is key to understanding organisms and driving advances in drug discovery, requiring interdisciplinary knowledge across chemistry and biology. Although large molecular language models have achieved notable success in interpreting molecular structures, their instruction datasets are limited to the specific knowledge from task-oriented datasets and do not fully cover the fundamental characteristics of molecules, hindering their abilities as general-purpose molecular assistants. To address this issue, we propose Mol-LLaMA, a large molecular language model that grasps the general knowledge centered on molecules via multi-modal instruction tuning. To this end, we design key data types that encompass the fundamental features of molecules, incorporating essential knowledge from molecular structures. In addition, to improve understanding of molecular features, we introduce a module that integrates complementary information from different molecular encoders, leveraging the distinct advantages of different molecular representations. Our experimental results demonstrate that Mol-LLaMA is capable of comprehending the general features of molecules and generating relevant responses to users' queries with detailed explanations, implying its potential as a general-purpose assistant for molecular analysis.

Recent advances in automated theorem proving (ATP) through LLMs have highlighted the potential of formal reasoning with Lean 4 codes. However, ATP has not yet be revolutionized by the recent posttraining scaling as demonstrated by Open AI O1/O3 and Deepseek R1. In this work, we investigate the entire posttraining of ATP, aiming to align it with breakthroughs in reasoning models in natural languages.To begin, we continual train current ATP models with a hybrid dataset, which consists of numerous statement-proof pairs, and additional data aimed at incorporating cognitive behaviors that emulate human reasoning and hypothesis refinement. Next, we explore reinforcement learning with the use of outcome reward returned by Lean 4 compiler. Through our designed continual training and reinforcement learning processes, we have successfully improved existing formal provers, including both DeepSeek-Prover-v1.5 and Goedel-Prover, achieving state-of-the-art performance in the field of whole-proof generation. For example, we achieve a 59.8% pass rate (pass@32) on MiniF2F. This is an on-going project and we will progressively update our findings, release our data and training details.

Despite their ability to understand chemical knowledge, large language models (LLMs) remain limited in their capacity to propose novel molecules with desired functions (e.g., drug-like properties). In addition, the molecules that LLMs propose can often be challenging to make, and are almost never compatible with automated synthesis approaches. To better enable the discovery of functional small molecules, LLMs need to learn a new molecular language that is more effective in predicting properties and inherently synced with automated synthesis technology. Current molecule LLMs are limited by representing molecules based on atoms. In this paper, we argue that just like tokenizing texts into meaning-bearing (sub-)word tokens instead of characters, molecules should be tokenized at the level of functional building blocks, i.e., parts of molecules that bring unique functions and serve as effective building blocks for real-world automated laboratory synthesis. This motivates us to propose mCLM, a modular Chemical-Language Model that comprises a bilingual language model that understands both natural language descriptions of functions and molecular blocks. mCLM front-loads synthesizability considerations while improving the predicted functions of molecules in a principled manner. mCLM, with only 3B parameters, achieves improvements in synthetic accessibility relative to 7 other leading generative AI methods including GPT-5. When tested on 122 out-of-distribution medicines using only building blocks/tokens that are compatible with automated modular synthesis, mCLM outperforms all baselines in property scores and synthetic accessibility. mCLM can also reason on multiple functions and iteratively self-improve to rescue drug candidates that failed late in clinical trials ("fallen angels").